• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在综合医疗服务系统中使用全面电子病历预测复发性艰难梭菌感染。

Prediction of Recurrent Clostridium Difficile Infection Using Comprehensive Electronic Medical Records in an Integrated Healthcare Delivery System.

机构信息

1Kaiser Permanente Division of Research,Oakland,California.

2Contra Costa Public Health Clinic Services,Martinez,California.

出版信息

Infect Control Hosp Epidemiol. 2017 Oct;38(10):1196-1203. doi: 10.1017/ice.2017.176. Epub 2017 Aug 24.

DOI:10.1017/ice.2017.176
PMID:28835289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6008100/
Abstract

UNLABELLED

BACKGROUND Predicting recurrent Clostridium difficile infection (rCDI) remains difficult.

METHODS

We employed a retrospective cohort design. Granular electronic medical record (EMR) data had been collected from patients hospitalized at 21 Kaiser Permanente Northern California hospitals. The derivation dataset (2007-2013) included data from 9,386 patients who experienced incident CDI (iCDI) and 1,311 who experienced their first CDI recurrences (rCDI). The validation dataset (2014) included data from 1,865 patients who experienced incident CDI and 144 who experienced rCDI. Using multiple techniques, including machine learning, we evaluated more than 150 potential predictors. Our final analyses evaluated 3 models with varying degrees of complexity and 1 previously published model. RESULTS Despite having a large multicenter cohort and access to granular EMR data (eg, vital signs, and laboratory test results), none of the models discriminated well (c statistics, 0.591-0.605), had good calibration, or had good explanatory power. CONCLUSIONS Our ability to predict rCDI remains limited. Given currently available EMR technology, improvements in prediction will require incorporating new variables because currently available data elements lack adequate explanatory power. Infect Control Hosp Epidemiol 2017;38:1196-1203.

摘要

背景

预测复发性艰难梭菌感染(rCDI)仍然具有挑战性。

方法

我们采用回顾性队列设计。从 21 家 Kaiser Permanente 北加州医院住院患者的颗粒状电子病历(EMR)数据中收集数据。推导数据集(2007-2013 年)包括 9386 例经历初次艰难梭菌感染(iCDI)和 1311 例经历首次艰难梭菌感染复发(rCDI)的患者数据。验证数据集(2014 年)包括 1865 例经历初次艰难梭菌感染和 144 例经历 rCDI 的患者数据。我们使用包括机器学习在内的多种技术评估了超过 150 个潜在的预测因子。我们的最终分析评估了 3 种具有不同复杂程度的模型和 1 种先前发表的模型。

结果

尽管有一个大型多中心队列和对颗粒状 EMR 数据(如生命体征和实验室检查结果)的访问,但没有一个模型能够很好地区分(c 统计量为 0.591-0.605)、具有良好的校准能力或具有良好的解释能力。

结论

我们预测 rCDI 的能力仍然有限。鉴于目前可用的 EMR 技术,要提高预测能力,需要纳入新的变量,因为目前可用的数据元素缺乏足够的解释能力。感染控制与医院流行病学 2017;38:1196-1203。

相似文献

1
Prediction of Recurrent Clostridium Difficile Infection Using Comprehensive Electronic Medical Records in an Integrated Healthcare Delivery System.在综合医疗服务系统中使用全面电子病历预测复发性艰难梭菌感染。
Infect Control Hosp Epidemiol. 2017 Oct;38(10):1196-1203. doi: 10.1017/ice.2017.176. Epub 2017 Aug 24.
2
Development and validation of a recurrent Clostridium difficile risk-prediction model.复发性艰难梭菌风险预测模型的开发与验证
J Hosp Med. 2014 Jul;9(7):418-23. doi: 10.1002/jhm.2189. Epub 2014 Apr 4.
3
Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study.初次艰难梭菌感染(CDI)发作的住院患者中复发性艰难梭菌感染(CDI)住院的危险因素:一项回顾性队列研究。
BMC Infect Dis. 2014 Jun 4;14:306. doi: 10.1186/1471-2334-14-306.
4
Utilization of Health Services Among Adults With Recurrent Clostridium difficile Infection: A 12-Year Population-Based Study.复发性艰难梭菌感染成人的医疗服务利用情况:一项基于人群的12年研究
Infect Control Hosp Epidemiol. 2017 Jan;38(1):45-52. doi: 10.1017/ice.2016.232. Epub 2016 Oct 20.
5
Impact of recurrent Clostridium difficile infection: hospitalization and patient quality of life.复发性艰难梭菌感染的影响:住院和患者生活质量。
J Antimicrob Chemother. 2017 Sep 1;72(9):2647-2656. doi: 10.1093/jac/dkx174.
6
A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.复发性艰难梭菌感染相关成本的综合研究
Infect Control Hosp Epidemiol. 2017 Feb;38(2):196-202. doi: 10.1017/ice.2016.246. Epub 2016 Nov 7.
7
Medication Exposure and Risk of Recurrent Clostridium difficile Infection in Community-Dwelling Older People and Nursing Home Residents.社区居住的老年人和养老院居民的药物暴露与复发性艰难梭菌感染的风险。
J Am Geriatr Soc. 2018 Feb;66(2):333-338. doi: 10.1111/jgs.15176. Epub 2017 Nov 9.
8
Lack of improvement in antimicrobial prescribing after a diagnosis of Clostridium difficile and impact on recurrence.艰难梭菌诊断后抗菌药物处方改善不足及其对复发的影响。
Am J Infect Control. 2018 Dec;46(12):1370-1374. doi: 10.1016/j.ajic.2018.04.213. Epub 2018 May 18.
9
Risk factors and impact of Clostridium difficile recurrence on haematology patients.艰难梭菌复发对血液学患者的危险因素及影响
J Antimicrob Chemother. 2017 May 1;72(5):1488-1495. doi: 10.1093/jac/dkx005.
10
Risk estimation for recurrent Clostridium difficile infection based on clinical factors.基于临床因素的复发性艰难梭菌感染风险评估。
Clin Infect Dis. 2014 May;58(10):1386-93. doi: 10.1093/cid/ciu107. Epub 2014 Mar 5.

引用本文的文献

1
Enhancing Infection Control in ICUS Through AI: A Literature Review.通过人工智能加强重症监护病房的感染控制:文献综述
Health Sci Rep. 2025 Jan 7;8(1):e70288. doi: 10.1002/hsr2.70288. eCollection 2025 Jan.
2
Validation of clinical risk tools for recurrent infection.复发性感染临床风险评估工具的验证
Infect Control Hosp Epidemiol. 2024 May 9;45(9):1-9. doi: 10.1017/ice.2024.75.
3
Prediction of hospital-acquired influenza using machine learning algorithms: a comparative study.使用机器学习算法预测医院获得性流感:一项比较研究。
BMC Infect Dis. 2024 May 2;24(1):466. doi: 10.1186/s12879-024-09358-1.
4
Harnessing of Artificial Intelligence for the Diagnosis and Prevention of Hospital-Acquired Infections: A Systematic Review.利用人工智能诊断和预防医院获得性感染:一项系统综述。
Diagnostics (Basel). 2024 Feb 23;14(5):484. doi: 10.3390/diagnostics14050484.
5
An integrated pipeline for prediction of Clostridioides difficile infection.用于艰难梭菌感染预测的集成管道。
Sci Rep. 2023 Oct 2;13(1):16532. doi: 10.1038/s41598-023-41753-7.
6
Microbiome profile and calprotectin levels as markers of risk of recurrent infection.微生物组特征和钙卫蛋白水平作为复发性感染风险的标志物。
Front Cell Infect Microbiol. 2023 Sep 13;13:1237500. doi: 10.3389/fcimb.2023.1237500. eCollection 2023.
7
Has the Flood Entered the Basement? A Systematic Literature Review about Machine Learning in Laboratory Medicine.洪水已侵入地下室了吗?关于检验医学中机器学习的系统文献综述。
Diagnostics (Basel). 2021 Feb 22;11(2):372. doi: 10.3390/diagnostics11020372.
8
Anti-toxin antibody is not associated with recurrent Clostridium difficile infection.抗毒素抗体与复发性艰难梭菌感染无关。
Anaerobe. 2021 Feb;67:102299. doi: 10.1016/j.anaerobe.2020.102299. Epub 2020 Nov 21.
9
Risk Factors for Primary Infection; Results From the Observational Study of Risk Factors for Infection in Hospitalized Patients With Infective Diarrhea (ORCHID).原发性感染的危险因素;感染性腹泻住院患者感染危险因素观察研究(ORCHID)的结果。
Front Public Health. 2020 Jul 17;8:293. doi: 10.3389/fpubh.2020.00293. eCollection 2020.
10
Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).艰难梭菌感染的诊断和治疗建议:西班牙化疗学会(SEQ)、西班牙内科学会(SEMI)和西班牙麻醉与复苏学会术后感染工作组(SEDAR)的官方临床实践指南。
Rev Esp Quimioter. 2020 Apr;33(2):151-175. doi: 10.37201/req/2065.2020. Epub 2020 Feb 20.

本文引用的文献

1
Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France.在法国使用非达霉素和万古霉素治疗艰难梭菌感染的成本效益分析。
J Med Econ. 2017 Jul;20(7):678-686. doi: 10.1080/13696998.2017.1302946. Epub 2017 Mar 16.
2
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.成人艰难梭菌相关性腹泻的抗生素治疗
Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD004610. doi: 10.1002/14651858.CD004610.pub5.
3
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.贝洛妥珠单抗预防复发性艰难梭菌感染。
N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615.
4
Early detection, prevention, and mitigation of critical illness outside intensive care settings.在重症监护病房以外的环境中对危重病进行早期检测、预防和缓解。
J Hosp Med. 2016 Nov;11 Suppl 1:S5-S10. doi: 10.1002/jhm.2653.
5
Piloting electronic medical record-based early detection of inpatient deterioration in community hospitals.在社区医院试点基于电子病历的住院患者病情恶化早期检测。
J Hosp Med. 2016 Nov;11 Suppl 1(Suppl 1):S18-S24. doi: 10.1002/jhm.2652.
6
Receipt of Antibiotics in Hospitalized Patients and Risk for Clostridium difficile Infection in Subsequent Patients Who Occupy the Same Bed.住院患者接受抗生素治疗与随后入住同一病房的艰难梭菌感染患者的风险。
JAMA Intern Med. 2016 Dec 1;176(12):1801-1808. doi: 10.1001/jamainternmed.2016.6193.
7
The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases.艰难梭菌感染的负担:来自美国行政数据库的艰难梭菌感染发病率估计
BMC Infect Dis. 2016 Apr 22;16:177. doi: 10.1186/s12879-016-1501-7.
8
Predicting the Risk of Clostridium difficile Infection upon Admission: A Score to Identify Patients for Antimicrobial Stewardship Efforts.入院时艰难梭菌感染风险预测:一种用于识别患者以开展抗菌药物管理工作的评分方法
Perm J. 2016 Winter;20(1):20-5. doi: 10.7812/TPP/15-049.
9
Clinical and Healthcare Burden of Multiple Recurrences of Clostridium difficile Infection.艰难梭菌感染多次复发的临床和医疗负担。
Clin Infect Dis. 2016 Mar 1;62(5):574-580. doi: 10.1093/cid/civ958. Epub 2015 Nov 17.
10
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Jun 11;372(24):2369-70. doi: 10.1056/NEJMc1505190.